BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19196661)

  • 1. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
    Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
    Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation.
    Secundino I; Lizcano A; Roupé KM; Wang X; Cole JN; Olson J; Ali SR; Dahesh S; Amayreh LK; Henningham A; Varki A; Nizet V
    J Mol Med (Berl); 2016 Feb; 94(2):219-33. PubMed ID: 26411873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9.
    Khatua B; Bhattacharya K; Mandal C
    J Leukoc Biol; 2012 Apr; 91(4):641-55. PubMed ID: 22241833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
    Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
    J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
    Chang YC; Olson J; Beasley FC; Tung C; Zhang J; Crocker PR; Varki A; Nizet V
    PLoS Pathog; 2014 Jan; 10(1):e1003846. PubMed ID: 24391502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
    Carlin AF; Chang YC; Areschoug T; Lindahl G; Hurtado-Ziola N; King CC; Varki A; Nizet V
    J Exp Med; 2009 Aug; 206(8):1691-9. PubMed ID: 19596804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual actions of group B
    Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.
    Saha S; Coady A; Sasmal A; Kawanishi K; Choudhury B; Yu H; Sorensen RU; Inostroza J; Schoenhofen IC; Chen X; Münster-Kühnel A; Sato C; Kitajima K; Ram S; Nizet V; Varki A
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
    Carlin AF; Lewis AL; Varki A; Nizet V
    J Bacteriol; 2007 Feb; 189(4):1231-7. PubMed ID: 16997964
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
    mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
    Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
    Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
    Saito M; Yamamoto S; Ozaki K; Tomioka Y; Suyama H; Morimatsu M; Nishijima KI; Yoshida SI; Ono E
    Microb Pathog; 2016 Oct; 99():106-110. PubMed ID: 27544323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
    Khatua B; Roy S; Mandal C
    Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus.
    Chang YC; Olson J; Louie A; Crocker PR; Varki A; Nizet V
    J Mol Med (Berl); 2014 Sep; 92(9):951-9. PubMed ID: 24788876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation.
    Lizcano A; Secundino I; Döhrmann S; Corriden R; Rohena C; Diaz S; Ghosh P; Deng L; Nizet V; Varki A
    Blood; 2017 Jun; 129(23):3100-3110. PubMed ID: 28416510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic Acid-Siglec-E Interactions During
    Mukherjee K; Khatua B; Mandal C
    Front Immunol; 2020; 11():332. PubMed ID: 32184783
    [No Abstract]   [Full Text] [Related]  

  • 19. Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
    Varchetta S; Brunetta E; Roberto A; Mikulak J; Hudspeth KL; Mondelli MU; Mavilio D
    PLoS One; 2012; 7(9):e45821. PubMed ID: 23029261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifarious roles of sialic acids in immunity.
    Varki A; Gagneux P
    Ann N Y Acad Sci; 2012 Apr; 1253(1):16-36. PubMed ID: 22524423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.